英文摘要 |
Background: The correlation between psoriasis severity and obesity has been verified; however, physicians generally do not consider obesity when they are selecting treatment methods for psoriasis or assessing treatment results. We evaluated the influence of obesity on psoriasis treatment involving indigo naturalis oil extract ointment. Methods: We collected the data of 116 patients from two clinical trials and divided these patients into three groups based on body mass index (BMI, kg/m^2), namely healthy weight (BMI < 25), overweight (25 ≤ BMI < 30), and obesity (BMI ≥ 30) groups. We compared their treatment response data (healthy weight versus overweight group, healthy weight versus obesity group, and overweight versus obesity group). Related metabolic data were also analyzed. Results: For treatment response, significant differences in Psoriasis Area and Severity Index reductions (%) were observed between the healthy weight and obesity groups (61.5% vs. 26.8%, P = 0.0093) and overweight and obesity groups (59.3% vs. 26.8%, P = 0.0207) but not between the healthy weight and overweight groups. Without obesity considered, patients with hypertension or other metabolic disorders (e.g., hyperlipidemia) that were verified by blood test data tended to exhibit slightly poorer treatment responses relative to patients without these conditions. Conclusions: Obesity and metabolic comorbidities should be considered by physicians in psoriasis treatment decisions; patients with obesity using indigo naturalis should be encouraged to manage their obesity to achieve better psoriasis treatment responses. Future studies should investigate whether patients' comorbidities influence the effectiveness of specific treatments. |